Browse studies

Find your next paid study

1 recruiting study matching your filters

A Single-Center, Open-Label, Single-Arm, Phase I Study With Dose Expansion Cohort of Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer

This is an open-label, Phase 1 study with a dose expansion cohort of Sacituzumab Govitecan in Combination with Cisplatin in Platinum Sensitive Recurrent Ovaria…

Ovarian CancerMalignant Neoplasm of Uterus

Icahn School of Medicine at Mount SinaiNCT06040970